Weekly Recap: Dohrmann to resign as Evotec SE CSO and JPMorgan WpHG filing
Alpha Vantage · TradingView · · AI-summarised by FinFlash
Evotec SE announced that its Chief Scientific Officer, Dr. Cord Dohrmann, will resign on September 30, 2026, after 16 years with the company; a search for his successor is underway. Separately, JPMorgan Chase filed a routine German major-holdings notice for Evotec SE on September 24, 2026. This filing is a standard ownership disclosure and does not include specific stake details.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.